Your account is not claimed yet. You can sign up with ORCID to claim your account.

Juan Roberto Rodriguez-Madoz (Juan R Rodriguez-Madoz, Juan Roberto Rodríguez-Madoz)

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2017-2022
Publications (10 Years): 9

Top Venues

Nature communications

Oncoimmunology

Journal of personalized medicine

Science advances

Centro de Investigación Médica Aplicada

Universidad de Navarra (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Centro de Investigación Médica Aplicada Nov 2o 2010

Spain

Researcher :: Cell Therapy

Education History

Universidad de Navarra

Spain

PHD

Publications

Marta Moya-Jódar, Giulia Coppiello, Juan Roberto Rodriguez-Madoz, Gloria Abizanda, Paula Barlabé, Amaia Vilas-Zornoza, Asier Ullate-Agote, Chiara Luongo, Ernesto Rodríguez-Tobón, Sergio Navarro-Serna, Evelyne París-Oller, Maria Oficialdegui, Xonia Carvajal-Vergara, Laura Ordovás, Felipe Prosper, Francisco Alberto García-Vázquez, Xabier L Aranguren
One-Step In Vitro Generation of ETV2-Null Pig Embryos. Animals : an open access journal from MDPI 12 (14) (2022)
Flor Navarro, Noelia Casares, Celia Martín-Otal, Aritz Lasarte-Cía, Marta Gorraiz, Patricia Sarrión, Diana Llopiz, David Repáraz, Nerea Varo, Juan Roberto Rodriguez-Madoz, Felipe Prosper, Sandra Hervás-Stubbs, Teresa Lozano, Juan Jose Lasarte
Overcoming T cell dysfunction in acidic pH to enhance adoptive T cell transfer immunotherapy. Oncoimmunology 11 (1) (2022)
Jianhao Peng, Guillermo Serrano, Ian M Traniello, Maria Eréndira Calleja-Cervantes, Ullas Valiya Chembazhi, Sushant Bangru, Teresa Ezponda, Juan Roberto Rodriguez-Madoz, Auinash Kalsotra, Felipe Prosper, Idoia Ochoa, Mikel Hernaez
SimiC enables the inference of complex gene regulatory dynamics across cell phenotypes. Communications biology 5 (1) (2022)
Paula Rodriguez-Marquez, Maria Eréndira Calleja-Cervantes, Guillermo Serrano, Marta Garrote, Maria L Palacios-Berraquero, Angel Martin-Mallo, Cristina Calviño-Sampedro, Marta Español-Rego, Candela Ceballos, Teresa Lozano, Patxi San Martin-Uriz, Amaia Vilas-Zornoza, Saray Rodriguez-Diaz, Rebeca Martinez-Turrillas, Patricia Jauregui, Diego Alignani, María Cruz Viguria, Margarita Redondo, Mariona Pascal, Beatriz Martin-Antonio, Manel Juan, Alvaro Urbano-Ispizua, Paula Rodriguez-Otero, Ana Alfonso, Juan José Lahuerta, Juan Jose Lasarte, Susana Inoges, Ascensión López-Díaz de Cerio, Jesús San F Miguel, Carlos Fernández de Larrea, Mikel Hernaez, Juan Roberto Rodriguez-Madoz, Felipe Prosper
CAR density influences antitumoral efficacy of BCMA CAR T cells and correlates with clinical outcome. Science advances 8 (39) (2022)
Maria Dolores Moya-Garzon, Jose Antonio Gomez-Vidal, Alfonso Alejo-Armijo, Joaquı N Altarejos, Juan Roberto Rodriguez-Madoz, Miguel Xavier Fernandes, Eduardo Salido, Sofía Salido, Monica Diaz-Gavilan
Small Molecule-Based Enzyme Inhibitors in the Treatment of Primary Hyperoxalurias. Journal of personalized medicine 11 (2) (2021)
Inês A Isidro, Pedro Vicente, Daniel A M Pais, Joana I Almeida, Mara Domingues, Bernardo Abecasis, Natalia Zapata-Linares, Juan Roberto Rodriguez-Madoz, Felipe Prosper, Anders Aspegren, Paula M Alves, Margarida Serra
Online monitoring of hiPSC expansion and hepatic differentiation in 3D culture by dielectric spectroscopy. Biotechnology and bioengineering 118 (9) (2021)
Nerea Zabaleta, Miren Barberia, Cristina Martín Higueras, Natalia Zapata-Linares, Isabel Betancor, Saray Rodriguez, Rebeca Martinez-Turrillas, Laura Torella, Africa Vales, Cristina Olagüe, Amaia Vilas-Zornoza, Laura Castro-Labrador, David Lara-Astiaso, Felipe Prosper, Eduardo Salido, Gloria Gonzalez-Aseguinolaza, Juan Roberto Rodriguez-Madoz
CRISPR/Cas9-mediated glycolate oxidase disruption is an efficacious and safe treatment for primary hyperoxaluria type I. Nature communications 9 (1) (2018)
Juan Roberto Rodriguez-Madoz, Edurne San Jose-Eneriz, Obdulia Rabal, Natalia Zapata-Linares, Estibaliz Miranda, Saray Rodriguez, Angelo Porciuncula, Amaia Vilas-Zornoza, Leire Garate, Victor Segura, Elizabeth Guruceaga, Xabier Agirre, Julen Oyarzabal, Felipe Prosper
Reversible dual inhibitor against G9a and DNMT1 improves human iPSC derivation enhancing MET and facilitating transcription factor engagement to the genome. PloS one 12 (12) (2017)
Edurne San José-Enériz, Xabier Agirre, Obdulia Rabal, Amaia Vilas-Zornoza, Juan A Sanchez-Arias, Estibaliz Miranda, Ana Ugarte, Sergio Roa, Bruno Paiva, Ander Estella-Hermoso de Mendoza, Rosa María Alvarez, Noelia Casares, Victor Segura, José I Martín-Subero, François-Xavier Ogi, Pierre Soule, Clara M Santiveri, Ramón Campos-Olivas, Giancarlo Castellano, Maite Garcia Fernandez de Barrena, Juan Roberto Rodriguez-Madoz, Maria José García-Barchino, Juan Jose Lasarte, Matias A Avila, Jose Angel Martinez-Climent, Julen Oyarzabal, Felipe Prosper
Discovery of first-in-class reversible dual small molecule inhibitors against G9a and DNMTs in hematological malignancies. Nature communications 8 (2017)

Juan Roberto Rodriguez-Madoz.css-eqlu8i{font-size:small;padding-left:4px;} (Juan R Rodriguez-Madoz, Juan Roberto Rodríguez-Madoz)

Publication Activity (10 Years)

Top Topics

Top Venues

Juan Roberto Rodriguez-Madoz (Juan R Rodriguez-Madoz, Juan Roberto Rodríguez-Madoz)